Aaron D. Showalter

2.1k citations

27 papers · 1.3k indexed · 1 hit paper · h-index 18

Impact in

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Treatment and Management
- Growth Hormone and Insulin-like Growth Factors
Cellular and Molecular Neuroscience top 5%
- Neuropeptides and Animal Physiology

Papers in

Endocrinology, Diabetes and Metabolism 19
- Diabetes Treatment and Management 14
- Growth Hormone and Insulin-like Growth Factors 5
Molecular Biology 22
- Receptor Mechanisms and Signaling 14
- Congenital heart defects research 3
- Chemical Synthesis and Analysis 2

Co-authors: Kyle W. Sloop Francis S. Willard Simon J. Rhodes David B. Wainscott James Ficorilli Cynthia Stutsman Matthew P. Coghlan Barbara Kluve‐Beckerman
Journals: Diabetes (4 papers)Gene (3 papers)Molecular Pharmacology (2 papers)Journal of Biological Chemistry (2 papers)PLoS ONE (2 papers)
Partner nations: United States Canada Australia

In The Last Decade

Aaron D. Showalter

27 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist 2020 · 314 citations

Peers

Countries citing papers authored by Aaron D. Showalter

Since Specialization

Citations

This map shows the geographic impact of Aaron D. Showalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron D. Showalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron D. Showalter more than expected).

Fields of papers citing papers by Aaron D. Showalter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron D. Showalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron D. Showalter. The network helps show where Aaron D. Showalter may publish in the future.

Co-authors

The 25 scholars most cited alongside Aaron D. Showalter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aaron D. Showalter Line = papers co-authored together Aaron D. Showalter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist JCI Insight ·Francis S. Willard, Jonathan D. Douros, M Gabe, Aaron D. Showalter, David B. Wainscott, Todd M. Suter, Megan E. Capozzi, Wijnand J. C. van der Velden, Cynthia Stutsman, Guemalli R. Cardona, Shweta Urva, Paul J. Emmerson, Jens J. Holst, David A. D’Alessio, Matthew P. Coghlan, Mette M. Rosenkilde, Jonathan E. Campbell, Kyle W. Sloop Hit paper breakdown →	2020	314
2	Synthetic protease-activated class B GPCRs Biochemical and Biophysical Research Communications ·Francis S. Willard, P. Pecenko, Aaron D. Showalter, Wenzhen Ma, Joseph D. Ho, J.M. Sauder, Kyle W. Sloop	2020	1
3	Structural insights into probe-dependent positive allosterism of the GLP-1 receptor Nature Chemical Biology ·Ana B. Bueno, Bingfa Sun, Francis S. Willard, Dan Feng, Joseph D. Ho, David B. Wainscott, Aaron D. Showalter, Michal Vieth, Qi Chen, Cynthia Stutsman, Betty Chau, James Ficorilli, Azaliya A. Imanova, Graham R. Cumming, Alma Jiménez, I. Rojo, Tong Sun Kobilka, Brian K. Kobilka, Kyle W. Sloop	2020	69
4	Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist Proceedings of the National Academy of Sciences ·Takahiro Kawai, Bingfa Sun, Hitoshi Yoshino, Dan Feng, Yoshiyuki Suzuki, Masanori Fukazawa, Shunsuke Nagao, David B. Wainscott, Aaron D. Showalter, Brian A. Droz, Tong Sun Kobilka, Matthew P. Coghlan, Francis S. Willard, Yoshiki Kawabe, Brian K. Kobilka, Kyle W. Sloop	2020	123
5	Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles Journal of Biological Chemistry ·Ana B. Bueno, Aaron D. Showalter, David B. Wainscott, Cynthia Stutsman, E.G. Dubovskaya, James Ficorilli, Over Cabrera, Francis S. Willard, Kyle W. Sloop	2016	48
6	Glucagon-Like Peptide-1 Receptor Ligand Interactions: Structural Cross Talk between Ligands and the Extracellular Domain PLoS ONE ·Graham M. West, Francis S. Willard, Kyle W. Sloop, Aaron D. Showalter, Bruce D. Pascal, Patrick R. Griffin	2014	11
7	A Novel Humanized GLP-1 Receptor Model Enables Both Affinity Purification and Cre-LoxP Deletion of the Receptor PLoS ONE ·Lucy S. Jun, Aaron D. Showalter, Alzira Silva Moreira, Feihan F. Dai, Wenzhen Ma, Tamer Coşkun, James Ficorilli, Michael B. Wheeler, M. Dodson Michael, Kyle W. Sloop	2014	25
8	Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-like Peptide-1 (GLP-1) Receptor Complex in Pancreatic β Cells Molecular & Cellular Proteomics ·Ming Zhang, Mélanie Robitaille, Aaron D. Showalter, Xinyi Huang, Ying Liu, Alpana Bhattacharjee, Francis S. Willard, Junfeng Han, D. Sean Froese, Wei Li, Herbert Y. Gaisano, Stéphane Angers, Kyle W. Sloop, Feihan F. Dai, Michael B. Wheeler	2014	53
9	Small Molecule Allosteric Modulation of the Glucagon-Like Peptide-1 Receptor Enhances the Insulinotropic Effect of Oxyntomodulin Molecular Pharmacology ·Francis S. Willard, Denise Wootten, Aaron D. Showalter, Emilia E. Savage, James Ficorilli, Thomas B. Farb, Krister Bokvist, Jorge Alsina‐Fernandez, Sebastian G. B. Furness, Arthur Christopoulos, Patrick M. Sexton, Kyle W. Sloop	2012	44
10	Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery Molecular Pharmacology ·Denise Wootten, Emilia E. Savage, Céline Valant, Lauren T. May, Kyle W. Sloop, James Ficorilli, Aaron D. Showalter, Francis S. Willard, Arthur Christopoulos, Patrick M. Sexton	2012	61
11	Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment Amyloid ·Merrill D. Benson, Richard Smith, Gene Hung, Barbara Kluve‐Beckerman, Aaron D. Showalter, Kyle W. Sloop, Brett P. Monia	2010	34
12	Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets Diabetes ·Kyle W. Sloop, Francis S. Willard, Martin Brenner, James Ficorilli, Koushik S, Aaron D. Showalter, Thomas B. Farb, Ludovica Pergolesi, Amy L. Cox, Han Chang-Yeal, Joshua A. Mitchell, Mark J. Tebbe, Michael J. Coghlan	2010	121
13	Specific Reduction of Hepatic Glucose 6-Phosphate Transporter-1 Ameliorates Diabetes while Avoiding Complications of Glycogen Storage Disease Journal of Biological Chemistry ·Kyle W. Sloop, Aaron D. Showalter, Amy L. Cox, Ludovica Pergolesi, Angela M. Siesky, Hongyan Zhang, Armando R. Irizarry, Susan F. Murray, Sheri Booten, Kevin Lam, Robert A. McKay, Brett P. Monia, Sanjay Bhanot, M. Dodson Michael	2007	10
14	Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides Muscle & Nerve ·Merrill D. Benson, Barbara Kluve‐Beckerman, Steven R. Zeldenrust, Angela M. Siesky, Diane Bodenmiller, Aaron D. Showalter, Kyle W. Sloop	2006	110
15	Conserved amino acid sequences confer nuclear localization upon the Prophet of Pit-1 pituitary transcription factor protein Gene ·Erico Wildan Kurniawan, Chad S. Hunter, Aaron D. Showalter, Timothy P. L. Smith, Riffat Naz Akhtar, Kyle W. Sloop, Joseph P. Bidwell, Simon J. Rhodes	2004	13
16	Cloning and analysis of axolotl ISL2 and LHX2 LIM‐homeodomain transcription factors genesis ·Aaron D. Showalter, Benjamin C. Yaden, Ellen A.G. Chernoff, Simon J. Rhodes	2004	6
17	Differential conservation of transcriptional domains of mammalian Prophet of Pit-1 proteins revealed by structural studies of the bovine gene and comparative functional analysis of the protein Gene ·Aaron D. Showalter, Timothy P. L. Smith, Gary L. Bennett, Kyle W. Sloop, Robert S. Mackay, Simon J. Rhodes	2002	22
18	Identification of porcine Lhx3 and SF1 as candidate genes for QTL affecting growth and reproduction traits in swine Animal Genetics ·Timothy P. L. Smith, Aaron D. Showalter, Kyle W. Sloop, G. A. Rohrer, Scott C. Fahrenkrug, Flávia Heiderich Dall'Orto, Simon J. Rhodes	2001	13
19	Analysis of the human LHX3 neuroendocrine transcription factor gene and mapping to the subtelomeric region of chromosome 9 Gene ·Kyle W. Sloop, Aaron D. Showalter, Paula Turunen, Mark J. Pettenati, Simon J. Rhodes	2000	30
20	Molecular Analysis ofLHX3andPROP-1in Pituitary Hormone Deficiency Patients with Posterior Pituitary Ectopia¹ The Journal of Clinical Endocrinology & Metabolism ·Kyle W. Sloop, Emily C. Walvoord, Aaron D. Showalter, Ora Hirsch Pescovitz, Simon J. Rhodes	2000	39

About Aaron D. Showalter

Aaron D. Showalter is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Cellular and Molecular Neuroscience, Genetics and Surgery, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (14 papers), Receptor Mechanisms and Signaling (14 papers), Pancreatic function and diabetes (9 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Neuropeptides and Animal Physiology (5 papers), Genetic Syndromes and Imprinting (4 papers), Congenital heart defects research (3 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (726 citations), Cellular and Molecular Neuroscience (298 citations), Molecular Biology (827 citations), Pharmacology (159 citations) and Surgery (311 citations). Aaron D. Showalter has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Kyle W. Sloop, Francis S. Willard, Simon J. Rhodes, David B. Wainscott, James Ficorilli, Cynthia Stutsman, Matthew P. Coghlan, Barbara Kluve‐Beckerman, Merrill D. Benson and Guemalli R. Cardona. Their work appears in journals such as Diabetes, Gene, Molecular Pharmacology, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact